News

Gladstone in the News October 21, 2021

‟Hybrid Immunity”: Why COVID Vaccination May Give Extra-Strong Protection after Infection

San Francisco Chronicle—Associate Investigator Nadia Roan, PhD, explains that people who receive COVID-19 vaccination after having had the disease harbor special immune cells that may provide stronger and more durable protection against future infections.

Gladstone Experts COVID-19 Infectious Disease Roan Lab

Gladstone in the News October 19, 2021

Natural Immunity Is Good. Getting Vaccinated after Being Sick with COVID-19 Is Better.

USA Today—Senior investigator Warner Greene, MD, PhD, comments on the benefits of vaccination after COVID-19 illness.

Gladstone Experts COVID-19 Center for HIV Cure Research Infectious Disease Greene Lab

Article October 19, 2021

How Talking about Personal Pronouns Can Build a More Inclusive Environment

Learn how you and your organization can make sharing pronouns commonplace

People Services LGBTQ Diversity

Article October 19, 2021

Maintaining Balance in the Brain

Gladstone scientists help explain how reducing the protein tau can prevent abnormal brain activity associated with Alzheimer’s disease, autism, and epilepsy

News Release Research (Publication) Alzheimer’s Disease Epilepsy Neurological Disease Mucke Lab

Article October 19, 2021

Meet Gladstone: Jane Srivastava

Jane Srivastava, director of Gladstone's Flow Cytometry Core, shares how her interest in science started at a young age and how lasers can be used for more than defeating stormtroopers

Profile Flow Cytometry Core

Article October 18, 2021

Gladstone Neuroscience Researcher Elected to the National Academy of Medicine

Lennart Mucke is recognized for his pioneering discoveries in research on Alzheimer’s disease and related disorders

Awards News Release Neurological Disease Mucke Lab

Gladstone in the News October 13, 2021

Diversity in Cardiology

Stanford Medicine News—A Collaboration Between Two Colleagues Seeks to End Research Disparities

Tcheandjieu Lab

Gladstone in the News October 12, 2021

New COVID-19 Pill Is Not a Substitute for the Vaccine, According to Experts—Here’s Why

ABC7 News—Gladstone President Deepak Srivastava, MD, and Senior Investigator Nevan Krogan, PhD, compare and contrast vaccines to Merck's new drug against COVID-19.

Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Krogan Lab Srivastava Lab

Article October 11, 2021

Immune Response to COVID-19 Vaccine Different with Prior Infection

Gladstone researchers studied how T cells respond to COVID-19 vaccines over the weeks following immunization

News Release Research (Publication) COVID-19 Infectious Disease Roan Lab

Article October 11, 2021

The Importance of LGBTQ+ Visibility in STEM

For National Coming Out Day, Gladstonians explain what factored into their decision to come out in the workplace

LGBTQ Diversity

Article October 11, 2021

Can an Already Approved Drug Treat Alzheimer’s Disease?

Researchers pinpoint an existing drug that reverses signs of Alzheimer’s disease in mice and may prevent the disease in humans

News Release Research (Publication) Alzheimer’s Disease Huang Lab

Article October 7, 2021

Honoring Indigenous Peoples’ Day

Gladstone Institutes acknowledges that we are located on the ancestral homeland of the Ramaytush Ohlone peoples

Diversity

Gladstone in the News October 7, 2021

Meet the Most Influential Women in Bay Area Business, Class of 2021

San Francisco Business Times—Senior Investigator Katerina Akassoglou, PhD, was picked by the San Francisco Business Times as one of the most influential women in business in the Bay Area this year.

Gladstone Experts Center for Neurovascular Brain Immunology Akassoglou Lab Diversity

Article October 6, 2021

Gladstone Investigators Win NIH Director’s Awards

The awards will support high-risk, high-reward research into a fundamentally new type of antiviral and a molecular strategy to fight cancer

Grants News Release COVID-19 Ramani Lab Weinberger Lab

Gladstone in the News October 4, 2021

Cutting-Edge Medical Research/SF Public Defender Sues Courts/Pauli Murray Documentary

KALW—Gladstone President Deepak Srivastava, MD, is one of two Bay Area leaders in COVID-19 research discussing current progress in the development of novel treatment, prevention and detection methods, at Gladstone and in the Bay Area.

Gladstone Experts COVID-19 Cardiovascular Disease